Keywise Capital Management Ltd decreased its stake in Taiwan Semiconductor Mfg Ltd (TSM) by 4.92% based on its latest 2019Q1 regulatory filing with the SEC. Keywise Capital Management Ltd sold 23,500 shares as the company’s stock declined 2.72% . The hedge fund held 453,800 shares of the semiconductors company at the end of 2019Q1, valued at $18.59M, down from 477,300 at the end of the previous reported quarter. Keywise Capital Management Ltd who had been investing in Taiwan Semiconductor Mfg Ltd for a number of months, seems to be less bullish one the $213.05B market cap company. The stock decreased 0.89% or $0.38 during the last trading session, reaching $41.53. About 2.34 million shares traded. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) has risen 3.75% since August 9, 2018 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical TSM News: 19/04/2018 – TSMC 2330.TW SAYS IT ORDERS EQUIPMENT FOR T$650 MLN; 15/05/2018 – SAMSUNG ELEC 005930.KS IN TALKS WITH ZTE 0763.HK , OTHER SMARTPHONE MAKERS TO SUPPLY EXYNOS CHIPS – EXEC; 19/04/2018 – TSMC cuts 2018 sales target on weak iPhone demand; 01/05/2018 – TSMC’S NANJING PLANT STARTS MASS PRODUCTION: ECONOMIC DAILY; 26/04/2018 – TSMC SAYS UNIT ORDERS EQUIPMENT FOR T$1.9 BLN; 07/03/2018 – Already under EU investigation, Taiwan company now accused of unfair competition; 16/05/2018 – TSMC 2330.TW SAYS IT ORDERS EQUIPMENT FOR T$630 MLN; 03/04/2018 – TSMC 2330.TW SAYS IT ORDERS EQUIPMENT FOR T$2.7 BLN; 10/04/2018 – TSMC 2330.TW SAYS MARCH SALES +20.8 PCT ON YEAR; 19/04/2018 – Taiwan Semiconductor Manufacturing (TMSC) said Thursday it expects second-quarter revenue to range between $7.8 billion and $7.9 billion, well below expectations
Comerica Bank decreased its stake in Regeneron Pharmaceuticals Inc (REGN) by 49.04% based on its latest 2019Q1 regulatory filing with the SEC. Comerica Bank sold 14,685 shares as the company’s stock declined 10.57% . The institutional investor held 15,261 shares of the health care company at the end of 2019Q1, valued at $6.23 million, down from 29,946 at the end of the previous reported quarter. Comerica Bank who had been investing in Regeneron Pharmaceuticals Inc for a number of months, seems to be less bullish one the $34.19B market cap company. The stock decreased 2.02% or $6.26 during the last trading session, reaching $303.61. About 312,137 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has declined 17.97% since August 9, 2018 and is downtrending. It has underperformed by 17.97% the S&P500. Some Historical REGN News: 19/03/2018 – REGENERON PHARMA-PHASE 3 TRIAL EVALUATING EYLEA INJECTION IN MODERATELY SEVERE TO SEVERE NON-PROLIFERATIVE DIABETIC RETINOPATHY MET PRIMARY ENDPOINT; 19/03/2018 – REGENERON PHARMACEUTICALS – EXPECT U.S. REGULATORY SUBMISSION FOR DIABETIC RETINOPATHY LATER THIS YEAR; 16/05/2018 – Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO; 03/05/2018 – REGENERON PHARMACEUTICALS INC SEES 2018 CAPITAL EXPENDITURES $420 MLN-$480 MILLION; 21/03/2018 – Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis; 11/05/2018 – Bayer: Second Indication for Eylea to Be Approved in China; 10/05/2018 – @JimCramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects; 21/05/2018 – New England Journal of Medicine Publishes Two Positive Phase 3 Trials Showing Dupixent(R) (dupilumab) Improved Moderate-To-Severe Asthma; 16/05/2018 – Dupixent(R) (dupilumab) Showed Positive Phase 3 Results in Adolescents With Inadequately Controlled Moderate-To-Severe Atopic Dermatitis; 19/03/2018 – #3 With Novartis and Roche gunning to carve up Eylea franchise, Regeneron has another PhIII success story to tell $NVS $RHHBY $REGN
More notable recent Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) news were published by: Fool.com which released: “Why ASML Holding Rose 10.4% in July – Motley Fool” on August 04, 2019, also Finance.Yahoo.com with their article: “Is Taiwan Semiconductor Mfg. Co. Ltd. (TSM) A Good Stock To Buy? – Yahoo Finance” published on June 07, 2019, Fool.com published: “Another Semiconductor Bellwether Points to Chip Strength in the Second Half – Motley Fool” on July 26, 2019. More interesting news about Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) were released by: Fool.com and their article: “Intel Gives Chip Stocks Their Third Boost in a Week – Motley Fool” published on August 01, 2019 as well as Investorplace.com‘s news article titled: “4 Nanotech Stocks to Watch for Explosive Innovation – Investorplace.com” with publication date: August 04, 2019.
More notable recent Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) news were published by: Nasdaq.com which released: “April 26th Options Now Available For Regeneron Pharmaceuticals (REGN) – Nasdaq” on March 11, 2019, also Nasdaq.com with their article: “Regeneron (REGN) Q2 Earnings Top Estimates, Eylea Sales Solid – Nasdaq” published on August 06, 2019, Nasdaq.com published: “Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings? – Nasdaq” on August 05, 2019. More interesting news about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) were released by: Nasdaq.com and their article: “Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss – Nasdaq” published on May 07, 2019 as well as Finance.Yahoo.com‘s news article titled: “Hereâ€™s What Hedge Funds Think About Regeneron Pharmaceuticals Inc (REGN) – Yahoo Finance” with publication date: June 14, 2019.
Investors sentiment increased to 1.96 in Q1 2019. Its up 0.83, from 1.13 in 2018Q4. It improved, as 34 investors sold REGN shares while 129 reduced holdings. 103 funds opened positions while 216 raised stakes. 71.25 million shares or 7.86% less from 77.33 million shares in 2018Q4 were reported. Eqis Cap Mgmt, California-based fund reported 6,577 shares. Moreover, Kelly Lawrence W Associates Ca has 0.32% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Evercore Wealth Mgmt Ltd Limited Liability Company owns 0.02% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 1,554 shares. Old Second Bancorporation Of Aurora holds 0.02% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) or 139 shares. 3,875 were accumulated by South Dakota Council. Sustainable Growth Advisers Lp holds 920,422 shares or 4.18% of its portfolio. Guardian Life Com Of America has 0.01% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 226 shares. Whittier Tru has 0% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 23 shares. Cwm Lc holds 22 shares or 0% of its portfolio. The Japan-based Mitsubishi Ufj & Corporation has invested 0.1% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Delta Asset Mngmt Limited Liability Company Tn invested in 4 shares. Pitcairn holds 0.07% or 1,633 shares in its portfolio. Mitsubishi Ufj Secs Com reported 60 shares. Caxton Associates LP owns 567 shares for 0.03% of their portfolio. Public Employees Retirement Systems Of Ohio owns 50,996 shares for 0.11% of their portfolio.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.